Feb 16, 2017 12:01 pm UTC| Business
BASEL, Switzerland and WATERTOWN, Mass., Feb. 16, 2017 -- Lonza Houston, Inc., a global leader in viral gene and cell therapy manufacturing, and Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage...
Feb 16, 2017 12:01 pm UTC| Business
BASEL, Switzerland and WATERTOWN, Mass., Feb. 16, 2017 -- Lonza Houston, Inc., a global leader in viral gene and cell therapy manufacturing, and Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage...
Feb 16, 2017 12:01 pm UTC| Business
TEL-AVIV, Israel, Feb. 16, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late...
Feb 16, 2017 12:01 pm UTC| Business
TEL-AVIV, Israel, Feb. 16, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late...
XOMA Appoints Matthew Perry to its Board of Directors
Feb 16, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 16, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Matthew Perry, President of BVF Partners L.P....
XOMA Appoints Matthew Perry to its Board of Directors
Feb 16, 2017 12:01 pm UTC| Business
BERKELEY, Calif., Feb. 16, 2017 -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Matthew Perry, President of BVF Partners L.P....
Feb 16, 2017 12:01 pm UTC| Business
WALTHAM, Mass., Feb. 16, 2017 -- Syndax (Nasdaq:SNDX) announced today that it will release its fourth quarter 2016 financial results on Thursday, March 2, 2017, after the close of the U.S. financial markets. In...